Back to Agenda
Preparing Clinical Documents for Public Release: The Issues of Transparency and Redaction
Session Chair(s)
Kerstin Dahlström, MPharm, MS
Director Transparency and Outsourcing , H. Lundbeck A/S, Denmark
EU Regulation No. 536/2014 (EMA policies 43+70) and EFPIA/PhRMA’s ’Principles for Responsible Clinical Trial Data Sharing’ are both initiatives to increase transparency of information on medical products and data on which regulatory decisions are based. The overall ambition is to support patients and society. However, we also have to protect patients’ privacy and safeguard personal data before sharing any information. This session will elaborate on this challenge but also give guidance on potential solutions and future ways of working.
Speaker(s)
Adel Salem
Senior Programmer, Novo Nordisk, Denmark
De-Identification of Patient Data in Rare Disease Clinical Studies – Special Considerations
Tracy Farrow
Senior Director Medical Writing, PPD, United Kingdom
The Impact of Clinical Trial Data Disclosure on Trial-related Documents: Redaction Requirements and Future Document Structure
Kerstin Dahlström, MPharm, MS
Director Transparency and Outsourcing , H. Lundbeck A/S, Denmark
How We Deliver It All Together – Reflections on Medical Writers’ Collaboration with Other Skill Groups
Have an account?